M&A Deal Summary |
|
|---|---|
| Date | 2018-11-30 |
| Target | GlaxoSmithKline - Consumer Healthcare Portfolio |
| Sector | Life Science |
| Buyer(s) |
Hildred Capital Partners
Crown Laboratories |
| Sellers(s) | GSK |
| Deal Type | Divestiture |
SEARCH BY
Hildred Capital Partners is a family-backed investment firm focused on active and passive investments across a range of securities. The Firm does not have any geographic preferences and will consider both equity and debt investing. Hildred Capital Partners was formed in 2014 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science M&A | 3 of 3 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2018 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-10-30 |
Crown Laboratories
Johnson City, Tennessee, United States Crown Laboratories is a specialty pharmaceutical company that produces medical products such as Blue Lizard Australian Sunscreen and medical products AlaQuin, AlaScalp, and Daxbia. Crown Laboratories currently operates three distinct areas of focus related to skincare and treating skin-related conditions: Consumer Healthcare Products, Prescription Products, and Contract Development and Manufacturing Services. Crown Laboratories was founded in 2000 and is based in Johnson City, Tennessee. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2025-02-04 |
Pharmaceutics International
Hunt Valley, Maryland, United States Pharmaceutics International (Pii) is a privately held contract development and manufacturing organization providing dosage form development and manufacturing services to the global pharmaceutical industry. It provides preformulation testing, formulation development, clinical and commercial CGMP manufacturing of solid, parenteral, inhalation, semi-solid and liquid dosage forms, clinical packaging and labeling, and analytical services. Pharmaceutics International was founded in 1994 and is based in Hunt Valley, Maryland. |
Sell | - |
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Life Science |
Crown Laboratories is a specialty pharmaceutical company that produces medical products such as Blue Lizard Australian Sunscreen and medical products AlaQuin, AlaScalp, and Daxbia. Crown Laboratories currently operates three distinct areas of focus related to skincare and treating skin-related conditions: Consumer Healthcare Products, Prescription Products, and Contract Development and Manufacturing Services. Crown Laboratories was founded in 2000 and is based in Johnson City, Tennessee.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 8 |
| Sector: Life Science M&A | 1 of 4 |
| Type: Divestiture M&A Deals | 1 of 3 |
| Country: United Kingdom M&A | 1 of 2 |
| Year: 2018 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-09-27 |
Crown Aesthetics
Dallas, Texas, United States Crown Aesthetics is a medical aesthetics treatments company dedicated to delivering innovative repair and restoration products to aesthetic practices around the world. Bellus’s non-invasive products give it a unique position in aesthetics, providing a range of products that draw first-time consumers to leading physician-directed practices globally. Most notable among its products is the SkinPen – a medical-grade micro-needling device used exclusively by healthcare professionals to improve the appearance of facial acne scars – the first micro-needling device in the industry to be granted clearance and marketing authorization by the U.S. Food and Drug Administration (FDA) for this indication. Crown Aesthetics was founded in 2012 and is based in Dallas, Texas. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-05-01 |
GlaxoSmithKline - Keri
Brentford, United Kingdom GlaxoSmithKline plc - Keri is a major skin care brand with a rich heritage. Keri has a long and successful history in the market, supported by dermatologists and healthcare practitioners across the world. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1715 |
| Sector | Life Science |
| Employees | 68,629 |
| Revenue | 31.4B GBP (2024) |
GSK is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GSK was founded in 1715 and is based in Brentford, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 24 |
| Sector: Life Science M&A | 12 of 17 |
| Type: Divestiture M&A Deals | 16 of 23 |
| Country: United Kingdom M&A | 8 of 13 |
| Year: 2018 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-07-19 |
GlaxoSmithKline - Raxibacumab
Brentford, United Kingdom GlaxoSmithKline plc - Raxibacumab is an indicated for the treatment of adult and pediatric patients with inhalational anthrax in combination with appropriate antibacterial drugs and for prophylaxis of inhalational anthrax when alternative therapies are not available or not appropriate. |
Sell | $130M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-12-03 |
Tesaro
Waltham, Massachusetts, United States Tesaro, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of patients with cancer. Tesaro develops and will commercialize safer and more effective supportive care agents and therapeutics. Tesaro, Inc. was founded in 2010 and is based in Waltham, Massachusetts. |
Buy | $5.1B |
